HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis.

AbstractOBJECTIVE:
To investigate the differences in bone turnover between diabetic patients and controls.
DESIGN:
A systematic review and meta-analysis.
METHODS:
A literature search was conducted using the databases Medline at PubMed and EMBASE. The free text search terms 'diabetes mellitus' and 'bone turnover', 'sclerostin', 'RANKL', 'osteoprotegerin', 'tartrate-resistant acid' and 'TRAP' were used. Studies were eligible if they investigated bone turnover markers in patients with diabetes compared with controls. Data were extracted by two reviewers.
RESULTS:
A total of 2881 papers were identified of which 66 studies were included. Serum levels of the bone resorption marker C-terminal cross-linked telopeptide (-0.10 ng/mL (-0.12, -0.08)) and the bone formation markers osteocalcin (-2.51 ng/mL (-3.01, -2.01)) and procollagen type 1 amino terminal propeptide (-10.80 ng/mL (-12.83, -8.77)) were all lower in patients with diabetes compared with controls. Furthermore, s-tartrate-resistant acid phosphatase was decreased in patients with type 2 diabetes (-0.31 U/L (-0.56, -0.05)) compared with controls. S-sclerostin was significantly higher in patients with type 2 diabetes (14.92 pmol/L (3.12, 26.72)) and patients with type 1 diabetes (3.24 pmol/L (1.52, 4.96)) compared with controls. Also, s-osteoprotegerin was increased among patients with diabetes compared with controls (2.67 pmol/L (0.21, 5.14)).
CONCLUSIONS:
Markers of both bone formation and bone resorption are decreased in patients with diabetes. This suggests that diabetes mellitus is a state of low bone turnover, which in turn may lead to more fragile bone. Altered levels of sclerostin and osteoprotegerin may be responsible for this.
AuthorsKatrine Hygum, Jakob Starup-Linde, Torben Harsløf, Peter Vestergaard, Bente L Langdahl
JournalEuropean journal of endocrinology (Eur J Endocrinol) Vol. 176 Issue 3 Pg. R137-R157 (Mar 2017) ISSN: 1479-683X [Electronic] England
PMID28049653 (Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
Copyright© 2017 European Society of Endocrinology.
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Biomarkers
  • Bone Morphogenetic Proteins
  • C-terminal cross-linking telopeptide of type II collagen, human
  • Collagen Type II
  • Genetic Markers
  • Osteoprotegerin
  • Peptide Fragments
  • Procollagen
  • SOST protein, human
  • procollagen Type I N-terminal peptide
  • Osteocalcin
  • Tartrate-Resistant Acid Phosphatase
Topics
  • Adaptor Proteins, Signal Transducing
  • Biomarkers (blood)
  • Bone Morphogenetic Proteins (blood)
  • Bone Remodeling (physiology)
  • Case-Control Studies
  • Collagen Type II (blood)
  • Diabetes Mellitus, Type 1 (blood, physiopathology)
  • Diabetes Mellitus, Type 2 (blood, physiopathology)
  • Genetic Markers
  • Humans
  • Osteocalcin (blood)
  • Osteoprotegerin (blood)
  • Peptide Fragments (blood)
  • Procollagen (blood)
  • Tartrate-Resistant Acid Phosphatase (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: